Dermal Joint Temperature to Screen For Radiographic RA Joint Damage
Dermal joint temperature may become a screening test to quickly and accurately identify individual RA patients at high risk for radiographic damage.
Year In Review RA
Can Underlying Depression Artificially Inflate DAS28 Scores in RA?
Inflated DAS28 may indicate significant psychological morbidity and related non-inflammatory pain, rather than true disease activity.
Novel Shared Genetic Risk Locus Identified for RA and SLE
A shared genetic locus (COG6) increased the risk for both systemic lupus erythematosus and rheumatoid arthritis.
Serum TNFi Troughs, Calprotectin Correlate With PDUS Synovitis in RA
Patients with rheumatoid arthritis and power Doppler ultrasound (PDUS)-evident synovitis had higher levels of serum calprotectin and lower tumor necrosis factor inhibitor serum troughs, suggesting that these values may help identify patients with PDUS synovitis in clinical remission or low disease activity.
Improvements in RA Fatigue Mediated By Changes in Central Pain
Fatigue contributes significantly to the morbidity associated with RA, however there is continued debate as to the mechanisms driving the fatigue process
Correcting Nutritional Alterations in Patients With Rheumatologic Disease to Improve Quality of Life
The inflammatory process associated with rheumatoid arthritis triggers increased metabolism. As the disease progresses muscle wasting begins to occur, so starting nutritional care early after making the diagnosis can help prevent this loss and preserve quality of life.
Rheumatology Advisor speaks with experts in clinical nutrition to address correcting nutritional abnormalities in patients with rheumatic diseases.
Role of Hypoxia in the Pathogenesis of Rheumatoid Arthritis
A new review explores the role of hypoxia in the pathogenesis of rheumatoid arthritis, with an eye toward implications for potential novel therapies.
No Evidence to Support MTX Reduction in MTX-IR Patients Initiated on ADA for RA
Lowering the dose of concomitant methotrexate therapy from ≥ 15 mg/week to 7 mg/week after starting adalimumab therapy may reduce the degree of RA clinical responses.
Comparing Relative Risks of CV Events in AS and RA
Researchers assessed incidence rates of age and sex-adjusted cardiovascular disease in patients with ankylosing spondylitis and rheumatoid arthritis, comparing these rates to those of the general population.
Differences in Oral, Subq MTX Bioavailability Linked to RA Outcomes
Methotrexate parenterally administered was associated with less treatment failure and lower disease activity scores in patients with early rheumatoid arthritis (ERA) as compared to oral dosing.
- Loading...
Loading...
Next post in Rheumatoid Arthritis
Loading... 
Loading...